ETON PHARMACEUTICALS ($ETON) posted quarterly earnings results for Q4 2025 on Thursday, March 19th. The company reported earnings of $0.05 per share, missing estimates of $0.09 by $0.04. The company also reported revenue of $21,280,000, beating estimates of $20,990,580 by $289,420.
Stock price change since market close: -3.26%
You can see Quiver Quantitative's $ETON stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ETON PHARMACEUTICALS Hedge Fund Activity
We have seen 49 institutional investors add shares of ETON PHARMACEUTICALS stock to their portfolio, and 66 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ROYAL BANK OF CANADA removed 478,175 shares (-99.8%) from their portfolio in Q4 2025, for an estimated $8,085,939
- DIVISADERO STREET CAPITAL MANAGEMENT, LP removed 298,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $5,039,180
- OBERWEIS ASSET MANAGEMENT INC/ added 238,940 shares (+124.2%) to their portfolio in Q4 2025, for an estimated $4,040,475
- CANNELL CAPITAL LLC removed 238,488 shares (-52.4%) from their portfolio in Q4 2025, for an estimated $4,032,832
- TWO SIGMA INVESTMENTS, LP removed 209,819 shares (-73.3%) from their portfolio in Q4 2025, for an estimated $3,548,039
- SOLEUS CAPITAL MANAGEMENT, L.P. removed 200,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $3,382,000
- JPMORGAN CHASE & CO removed 165,978 shares (-47.2%) from their portfolio in Q4 2025, for an estimated $2,806,687
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ETON PHARMACEUTICALS Price Targets
Multiple analysts have issued price targets for $ETON recently. We have seen 2 analysts offer price targets for $ETON in the last 6 months, with a median target of $33.5.
Here are some recent targets:
- Chase Knickerbocker from Craig-Hallum set a target price of $30.0 on 03/03/2026
- Swayampakula Ramakanth from HC Wainwright & Co. set a target price of $37.0 on 03/02/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
